Insight Molecular Diagnostics (IMDX) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Insight Molecular Diagnostics (IMDX) over the past year, gaining 66.2% versus a loss of 6.0%. Over five years, TKNO leads with a -62.3% price change compared with -94.9% for IMDX. Alpha Teknova is the larger company by market cap ($467.6 million vs $113.2 million), about 4.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMDX | TKNO |
|---|---|---|
| Share price | $3.46 | $8.71 |
| Market cap | $113.23M | $467.62M |
| 1-day change | +2.37% | -0.46% |
| YTD return | -53.87% | +129.21% |
| 1-year return | -5.98% | +66.22% |
| 5-year return | -94.91% | -62.29% |
| EPS (TTM) | $-1.52 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.51 | $9.48 |
| 52-week low | $2.42 | $1.91 |
| Distance from 52-week high | -59.34% | -8.12% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +3.33% |
| Average volume | 234.39K | 230.41K |
| Shares outstanding | 32.72M | 53.69M |
| Employees | — | 158 |
| Sector | Health Care | Healthcare |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alpha Teknova is about 4.1 times larger than Insight Molecular Diagnostics by market value ($467.62M vs $113.23M).
- TKNO has outperformed IMDX by 72.2 percentage points over the past year.
- The two companies sit in different sectors: Insight Molecular Diagnostics in Health Care and Alpha Teknova in Healthcare.
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 158 employees
IMDX vs TKNO FAQ
Which is bigger, Insight Molecular Diagnostics or Alpha Teknova?
Alpha Teknova (TKNO) is larger, with a market capitalization of $467.62M compared with $113.23M for Insight Molecular Diagnostics (IMDX).
Which stock has performed better over the past year, IMDX or TKNO?
TKNO returned +66.22% over the past 12 months, compared with -5.98% for IMDX (price return, excluding dividends). Past performance does not predict future results.
Are Insight Molecular Diagnostics and Alpha Teknova in the same industry?
No. Insight Molecular Diagnostics is in the Health Care sector, while Alpha Teknova is in Healthcare.